Quantcast
Channel: Peter Trayhurn Blog
Viewing all articles
Browse latest Browse all 937

Fighting recurrence 2 - the targeted kitchen sink approach - yes I am back on the ketogenic diet

$
0
0

Ellen seems to have written, a good book, I could have done something similar myself, but she has beat to it, good on her. she will save millions. I have so much faith in this science. If your onc don't like, politely tell him to jump in the lack. Its your life, its your choice, dont forget that!


Of course antibodies, diet, exercise, sauna, meditation, drugs oh I love all the drugs, but not heavy duty chemo, unless no other options.
e-commerce powered by e-junkie
  • Click here to download The Fight Cancer with a Ketogenic Diet eBook
    Thank you for ordering The Fight Cancer with a Ketogenic Diet eBook.
    I hope you find it helpful in addressing your questions about how to use a ketogenic diet to treat cancer.
    If you have any problems downloading the eBook file, please email me at bugellen@gmail.com and I'll do my best to get right back to you to fix the issue.
    Wishing you excellent health,
    Ellen Davis
    Author, www.ketogenic-diet-resource.com


    I hate to say I told you so, but DAM it feels good to be right, especially when its your own ass in the firing line.


    http://www.discoverymedicine.com/Bo-Xiang/2013/05/24/colorectal-cancer-immunotherapy/
    Conclusion
    The limitations of surgery and adjuvant chemo/radio/antibody therapies to treat CRC patients necessitate the development of novel approaches, including immunotherapy. While some clinical trials utilizing cancer vaccines have demonstrated objective clinical responses in immunized patients with metastatic CRC, more work is needed. The approval of the first cancer vaccine, sipuleucel-T, should establish a new paradigm for the development, clinical testing and regulatory approval of future cancer vaccines for colorectal and other malignancies. ACT in clinical trials for CRC has resulted in severe toxicities; however, successes targeting melanoma and leukemia have demonstrated the feasibility of this approach. Alternative approaches to minimize toxicities in CRC patients by identifying appropriate antigen targets or interventions that reduce the severity of toxicities will be necessary for this therapy to achieve success. While it is unlikely that a single therapy will be a universal cure for CRC, a future convergence of therapeutics including surgery, chemotherapy, immunotherapy, and possibly others may ultimately change patient outcomes in CRC.

    "We are excited about exploring the potential of our cancer immunotherapy platform in colorectal cancer," said James Breitmeyer, EVP of Bavarian Nordic and President of the Cancer Vaccine Division. "We are optimistic that CV-301 offers patients with colon cancer the same promise of extended survival with a favorable side effect profile that our other product candidate, PROSTVAC® offers patients with advanced prostate cancer. This provides an excellent opportunity to broaden our cancer immunotherapy clinical pipeline with yet another late-stage product candidate. We now look forward to assessing the complete CV-301 portfolio and expect to present the future development strategy later this year."
    This announcement does not affect the company's expectations for the financial results for 2013.

    http://csn.cancer.org/node/259495#comment-1374169 great post by steve, I think I met CV301 guys at the cimt conference, I met so many colorectal researchers.

    New

    thats where all my detectable tumours disappeared, only immunotherapy, it works.
    of course it works better with less disease.
    absolutely fanastic news about immunotherapies, I hope all those were negative about the potential of these therapies can see that the exact therapies I have used to control my extensive metastatic disease are available for all one day.
    Alas it seems many patients have to wait for their doctors guidance. I guess thats the way it is, but for those patients willing to boldly go where noman has gone before, well lets just say there is solid hope based on lots of science.
    everyone with colorectal cancer should be demanding these therapies, or at least asking their oncologist the question ?
    you can change oncologists, I am up to number 7, i think!
    i wonder if how many will read this news, and feel some real hope ? its worked well for me, its worked well for many in the studies.
    for me the path least trodden represents the best cance of survival. So now the upset in the colorectal patient community wont be do these therapies work, its more the question when can I have access to these. thats another very complicated and challenging hurdle.
    If you have the resources, an option to consider is trying these therapies. I have recommended these therapies potential for at least 10 months here, and am very satisfied that science and evidence are shining a spot light on the path I took.
    hugs,
    Pete
    ps cut me some slack everyone its my 3 year anniversay today of being diagnosed.

    http://csn.cancer.org/node/259346 this discussion is how I found ellen books, see you try and help someone else and calma rewards you, often very quickly, then I was drawn back to csn and I noticed steve post above about immunotherapies.

Viewing all articles
Browse latest Browse all 937

Trending Articles